Author
Listed:
- Vishal A. Deshmukh
(The Scripps Research Institute, 10550, North Torrey Pines Road, La Jolla, California 92037, USA)
- Virginie Tardif
(The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA)
- Costas A. Lyssiotis
(The Scripps Research Institute, 10550, North Torrey Pines Road, La Jolla, California 92037, USA
Present Address: Weill Cornell Medical College, 1300 York Avenue, New York, New York 10065, USA.)
- Chelsea C. Green
(The Scripps Research Institute, 10550, North Torrey Pines Road, La Jolla, California 92037, USA)
- Bilal Kerman
(Laboratory of Genetics, The Salk Institute for Biological Sciences, 10010 North Torrey Pines Road, La Jolla, California 92037, USA)
- Hyung Joon Kim
(Laboratory of Genetics, The Salk Institute for Biological Sciences, 10010 North Torrey Pines Road, La Jolla, California 92037, USA)
- Krishnan Padmanabhan
(Laboratory of Genetics, The Salk Institute for Biological Sciences, 10010 North Torrey Pines Road, La Jolla, California 92037, USA)
- Jonathan G. Swoboda
(The Scripps Research Institute, 10550, North Torrey Pines Road, La Jolla, California 92037, USA)
- Insha Ahmad
(The Scripps Research Institute, 10550, North Torrey Pines Road, La Jolla, California 92037, USA)
- Toru Kondo
(Institute for Genetic Medicine, Hokkaido University, Kita-15, Nishi- 7, Kita-ku, Sapporo 060-0815, Japan)
- Fred H. Gage
(Laboratory of Genetics, The Salk Institute for Biological Sciences, 10010 North Torrey Pines Road, La Jolla, California 92037, USA)
- Argyrios N. Theofilopoulos
(The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA)
- Brian R. Lawson
(The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA)
- Peter G. Schultz
(The Scripps Research Institute, 10550, North Torrey Pines Road, La Jolla, California 92037, USA
The California Institute for Biomedical Research, 11119 North Torrey Pines Road)
- Luke L. Lairson
(The Scripps Research Institute, 10550, North Torrey Pines Road, La Jolla, California 92037, USA
The California Institute for Biomedical Research, 11119 North Torrey Pines Road)
Abstract
Progressive phases of multiple sclerosis are associated with inhibited differentiation of the progenitor cell population that generates the mature oligodendrocytes required for remyelination and disease remission. To identify selective inducers of oligodendrocyte differentiation, we performed an image-based screen for myelin basic protein (MBP) expression using primary rat optic-nerve-derived progenitor cells. Here we show that among the most effective compounds identifed was benztropine, which significantly decreases clinical severity in the experimental autoimmune encephalomyelitis (EAE) model of relapsing-remitting multiple sclerosis when administered alone or in combination with approved immunosuppressive treatments for multiple sclerosis. Evidence from a cuprizone-induced model of demyelination, in vitro and in vivo T-cell assays and EAE adoptive transfer experiments indicated that the observed efficacy of this drug results directly from an enhancement of remyelination rather than immune suppression. Pharmacological studies indicate that benztropine functions by a mechanism that involves direct antagonism of M1 and/or M3 muscarinic receptors. These studies should facilitate the development of effective new therapies for the treatment of multiple sclerosis that complement established immunosuppressive approaches.
Suggested Citation
Vishal A. Deshmukh & Virginie Tardif & Costas A. Lyssiotis & Chelsea C. Green & Bilal Kerman & Hyung Joon Kim & Krishnan Padmanabhan & Jonathan G. Swoboda & Insha Ahmad & Toru Kondo & Fred H. Gage & A, 2013.
"A regenerative approach to the treatment of multiple sclerosis,"
Nature, Nature, vol. 502(7471), pages 327-332, October.
Handle:
RePEc:nat:nature:v:502:y:2013:i:7471:d:10.1038_nature12647
DOI: 10.1038/nature12647
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Giampiero Porcu & Eliseo Serone & Velia De Nardis & Daniele Di Giandomenico & Giuseppe Lucisano & Marco Scardapane & Anna Poma & Antonella Ragnini-Wilson, 2015.
"Clobetasol and Halcinonide Act as Smoothened Agonists to Promote Myelin Gene Expression and RxRγ Receptor Activation,"
PLOS ONE, Public Library of Science, vol. 10(12), pages 1-22, December.
- Jaime Gonzalez Cardona & Matthew D Smith & Jingya Wang & Leslie Kirby & Jason T Schott & Todd Davidson & Jodi L Karnell & Katharine A Whartenby & Peter A Calabresi, 2019.
"Quetiapine has an additive effect to triiodothyronine in inducing differentiation of oligodendrocyte precursor cells through induction of cholesterol biosynthesis,"
PLOS ONE, Public Library of Science, vol. 14(9), pages 1-19, September.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:502:y:2013:i:7471:d:10.1038_nature12647. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.